NCT01428817View on ClinicalTrials.gov

Carbetocin at Elective Cesarean Delivery Part 2

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Carbetocin

20mcg carbetocin, IV, over 1 minute following delivery of the fetal head.

DRUG

Carbetocin

40mcg carbetocin, IV, over 1 minute following delivery of the fetal head.

DRUG

Carbetocin

60mcg carbetocin, IV, over 1 minute following delivery of the fetal head.

DRUG

Carbetocin

80mcg carbetocin, IV, over 1 minute following delivery of the fetal head.

DRUG

Carbetocin

100mcg carbetocin, IV, over 1 minute following delivery of the fetal head.

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT01428817 - Carbetocin at Elective Cesarean Delivery Part 2 | Biotech Hunter | Biotech Hunter